Does BPC-157 need to be injected near the injury?
Not necessarily. Clinics administer BPC-157 by subcutaneous injection either near the injured area or into the abdomen. Many prefer near the injury for tendon and joint problems; others say it is not required, because the peptide enters the circulation. No study has compared the two injection sites in people.
Near the injury
Into the abdomen
Other clinics say the site matters less. One says the injection site is not always the main factor in results, because the peptide enters the circulation4. Another describes abdominal injection as a practical alternative when the injury site cannot be reached, with a response that may be somewhat slower2. Clinicians describe abdominal injection as simpler and lower-risk, and injection near a joint as more technically challenging5. A further clinic uses either site6.
What the human studies used
The three published human studies did not use either subcutaneous site: one gave injections into the knee joint, one injected the bladder wall during cystoscopy, and one gave infusions into a vein789. No study has compared injection near an injury with abdominal injection in people.
Both sites, with the doses clinics use, are set out in How is BPC-157 taken?.
Research status
References
- Beyond Stem Cells Medical Spa, Littleton, Colorado. Best way to take BPC-157: the complete guide to dosing and administration; read October 26 and 29, 2026.Source →
- Perfect B Aesthetic Medicine, Doral, Florida. BPC-157 dosage protocol; read October 26 and 29, 2026.Source →
- BPC-157 treatment pageClinicDr. Patrick Taylor / PeptideWise (drpattaylor.com). Read October 25, 2026. Clinician-published protocol, cited for its own published dose, schedule, route and the side effects it lists; it ties no study to any dose.drpattaylor.com →
- Phoenix Peptide Therapy (Roots and Branches), Elena Nott, DAcHM, LAc. Does BPC-157 Need to Be Injected Into the Injury Site? Dated May 18, 2026 (page metadata); read October 29, 2026.Source →
- Ubie Doctor's Note (Ubie Health), reviewed by Yoshinori Abe, MD, Internal Medicine. Stop Injecting BPC-157 Wrong! Joint vs. Belly? (MD Guide). Published October 7, 2026; read October 29, 2026.Source →
- Moonshot Medical and Performance, Park Ridge, Illinois; medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC. BPC-157: Benefits, Dosing & Side Effects (2026). Updated March 24, 2026; read October 29, 2026.Source →
- Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainHuman, retrospectiveLee E, Padgett B. Altern Ther Health Med. 2021;27(4):8-13.Key finding: Phone follow-up of 16 of 17 patients after a knee-joint injection: 14 of 16 reported significant improvement (11 of 12 given BPC-157 alone, 3 of 4 given it with thymosin beta-4); no control group or validated scale.PubMed 34324435 →
- Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot StudyHuman pilotLee E, Walker C, Ayadi B. Altern Ther Health Med. 2024;30(10):12-17.Key finding: 12 women given one 10 mg injection into the bladder wall at cystoscopy: 10 reported complete resolution and 2 reported 80% improvement; no adverse events; no control group.PubMed 39325560 →
- Safety of Intravenous Infusion of BPC157 in Humans: A Pilot StudyHuman pilotLee E, Burgess K. Altern Ther Health Med. 2025;31(5):20-24.Key finding: 2 adults given 10 mg then 20 mg by infusion on consecutive days showed no change in heart, liver, kidney, thyroid or glucose markers; no side effects reported. Both had received intravenous BPC-157 before.PubMed 40131143 →
More on this compound
For other common questions regarding BPC-157, see the full BPC-157 profile.
Where to Buy
Research use only. Not medical advice.
We may earn commissions from peptide vendor affiliate links.
Updated